000227.KS · 유유제약2우B
South Korea · RS rating 35 · As of 2026-10-14
| Price | 7,930.00 KRW |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 75 / 27 / 36 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 20 / 20 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +3.2% |
| Distance from 52-week high | +32.0% |
| Market cap (USD) | – |